Form 4: Teradyne Insider Trades: Mills Regan Sells Shares
Statement of Changes in Beneficial Ownership
Regan Mills, President of Product Test at Teradyne, Inc., reported transactions involving the sale of company stock.
Summary
- Regan Mills, President of Product Test at Teradyne, Inc., engaged in stock transactions on April 1st and April 2nd, 2026.
- On April 1st, 222 shares of common stock were withheld by the issuer to cover tax obligations related to the vesting of restricted stock units.
- On April 2nd, 252 shares of common stock were sold as part of a pre-arranged sales plan adopted on November 25, 2025, intended to comply with Rule 10b5-1.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing neutrally as it reports routine insider transactions under a pre-established plan, without providing new financial or strategic information.
Negatives
- Insider selling activity, though executed under a 10b5-1 plan, can sometimes be perceived negatively by the market.
Risks
- The primary risk associated with insider selling, even under a 10b5-1 plan, is the potential for negative market perception and impact on share price.
- While the sales are part of a pre-defined plan, any significant future sales by insiders could signal a lack of confidence in the company's short-term prospects.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing, which is a standard Form 4 reporting insider transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions. While this filing details specific sales by a Teradyne executive, it does not provide strategic or financial performance insights. The adoption of a Rule 10b5-1 plan is a common practice for insiders to diversify their holdings or manage tax liabilities in a structured manner, mitigating concerns about trading on material non-public information.
Stakeholder Impact
- Shareholders: The sale of shares by an executive, even under a 10b5-1 plan, may lead to short-term market scrutiny, though it does not inherently signal negative company performance.
- Employees: No direct impact on employees is indicated by this filing.
- Creditors: No impact on creditors is indicated.
- Suppliers: No impact on suppliers is indicated.
Key Dates
| Date | Description |
|---|---|
| 2025-11-25 | Date the Rule 10b5-1 sales plan was adopted by Regan Mills. |
| 2026-04-01 | Date of transaction where shares were withheld for tax obligations and earliest transaction date reported. |
| 2026-04-02 | Date of transaction where shares were sold under the 10b5-1 plan. |
| 2026-04-03 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Teradyne, TER, Form 4, Insider Trading, Stock Sale, Regan Mills, 10b5-1 Plan, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.